Skip to main content
Back
CVSA logo

Covista Inc.

Data quality: 100%
CVSA
NYSE Consumer Cyclical Personal Products & Services
$109.64
▲ $3.15 (2.96%)
Mkt Cap: 3.78B
Day Range
$106.27 $111.22
52-Week Range
$86.97 $156.26
Volume
254,782
50D / 200D Avg
$105.60 / $117.40
Prev Close
$106.49

Price History

Financial Trends

Peer Comparison

vs Consumer Cyclical sector median (609 peers)

Metric Stock Sector Median
P/E 16.3 11.1
P/B 2.6 1.4
ROE % 16.6 10.7
Net Margin % 13.0 5.1
Rev Growth 5Y % 18.5 8.3
D/E 0.5 0.8

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $11.20
$11.14 – $11.26
 2.4 B 1
FY2028 $10.00
$9.95 – $10.06
 2.2 B 1
FY2027 $8.80
$8.63 – $8.97
 2.1 B 2

Key Takeaways

Revenue grew 18.50% annually over 5 years — strong growth
Earnings grew 70.11% over the past year
ROE of 16.60% — decent returns on equity
Generating 287.57M in free cash flow
PEG of 0.25 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.65%

Growth

Revenue Growth (5Y)
18.50%
Revenue (1Y)12.85%
Earnings (1Y)70.11%
FCF Growth (3Y)31.66%

Quality

Return on Equity
16.60%
ROIC11.60%
Net Margin13.01%
Op. Margin19.10%

Safety

Debt / Equity
0.54
Current Ratio0.82
Interest Coverage6.53

Valuation

P/E Ratio
16.26
P/B Ratio2.64
EV/EBITDA12.76
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 12.85% Revenue Growth (3Y) 11.02%
Earnings Growth (1Y) 70.11% Earnings Growth (3Y) 54.93%
Revenue Growth (5Y) 18.50% Earnings Growth (5Y) 31.88%
Profitability
Revenue (TTM) 1.79B Net Income (TTM) 232.68M
ROE 16.60% ROA 8.45%
Gross Margin 56.86% Operating Margin 19.10%
Net Margin 13.01% Free Cash Flow (TTM) 287.57M
ROIC 11.60% FCF Growth (3Y) 31.66%
Safety
Debt / Equity 0.54 Current Ratio 0.82
Interest Coverage 6.53 Dividend Yield 0.00%
Valuation
P/E Ratio 16.26 P/B Ratio 2.64
P/S Ratio 2.12 PEG Ratio 0.25
EV/EBITDA 12.76 Dividend Yield 0.00%
Market Cap 3.78B Enterprise Value 4.36B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.79B 1.58B 1.45B 1.38B 906.90M
Net Income 232.68M 136.78M 96.93M -162.49M 76.91M
EPS (Diluted) 6.07 3.42 2.23 -3.36 1.49
Gross Profit 1.02B 886.10M 774.10M 651.93M 460.02M
Operating Income 341.54M 217.05M 226.33M 155.57M 156.51M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.75B 2.74B 2.81B 3.03B 3.08B
Total Liabilities 1.32B 1.37B 1.35B 1.54B 1.78B
Shareholders' Equity 1.43B 1.37B 1.46B 1.49B 1.30B
Total Debt 774.00M 847.85M 896.19M 1.07B 1.30B
Cash & Equivalents 199.60M 219.31M 272.19M 346.97M 476.38M
Current Assets 416.19M 418.09M 480.30M 557.10M 1.51B
Current Liabilities 507.93M 487.66M 431.20M 423.65M 408.81M

Strategy Scores

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#688 of 1024
37
Growth + Value Growth at a Reasonable Price (Peter Lynch)
#100 of 326
60
Custom Balanced Risk
#82 of 148
45
Custom Lower Risk
#53 of 136
48

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Entered Balanced Risk
Mar 24, 2026
Entered Lower Risk
Mar 24, 2026